These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38240497)

  • 1. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy.
    Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S
    Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
    Camperi J; Moshref M; Dai L; Lee HY
    Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering.
    Shin J; Lee N; Cho S; Cho BK
    Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
    Zhang S; Shen J; Li D; Cheng Y
    Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
    Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
    Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells.
    Ye Y; Zhang X; Xie F; Xu B; Xie P; Yang T; Shi Q; Zhang CY; Zhang Y; Chen J; Jiang X; Li J
    Biomater Sci; 2020 May; 8(10):2966-2976. PubMed ID: 32342086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
    Hosseini ES; Nikkhah M; Hosseinkhani S
    Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
    [No Abstract]   [Full Text] [Related]  

  • 12. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application.
    Sun B; Chen H; Gao X
    J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a pVEC peptide-based ribonucleoprotein (RNP) delivery system for genome editing using CRISPR/Cas9 in Chlamydomonas reinhardtii.
    Kang S; Jeon S; Kim S; Chang YK; Kim YC
    Sci Rep; 2020 Dec; 10(1):22158. PubMed ID: 33335164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
    Bykonya AG; Lavrov AV; Smirnikhina SA
    Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
    Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
    Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.
    Chooi WH; Chin JS; Chew SY
    Methods Mol Biol; 2021; 2211():183-191. PubMed ID: 33336278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
    Abbasi S; Uchida S; Toh K; Tockary TA; Dirisala A; Hayashi K; Fukushima S; Kataoka K
    J Control Release; 2021 Apr; 332():260-268. PubMed ID: 33647431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
    Im SH; Jang M; Park JH; Chung HJ
    J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.